Transplant and cellular therapy in Las Vegas
CDC guidance now recommends that moderately to severely immunocompromised patients receive an additional (third) dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna). If you have undergone anti-cancer therapy in the past year, you are within 1 year of stem cell transplantation or are receiving medications that suppress your immune system, you are encouraged to obtain a third COVID-19 vaccination shot. If you received the Johnson & Johnson single dose vaccination, please consult your doctor regarding next steps. Find vaccination locations here.
If you are within 100 days of a stem cell transplantation, we do not recommend that you receive a COVID-19 vaccination until you are cleared by your care team to do so. If you are currently on a clinical research trial, please contact your clinical research team for more guidance. Please contact your care coordinator if you have additional questions about receiving an additional COVID-19 vaccine shot.
The Sarah Cannon Transplant and Cellular Therapy Program at MountainView Hospital has internationally-recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) for adult adult autologous transplantation and immune effector cell therapy (IECT).
FACT Standards for cellular therapy require a robust infrastructure for the full continuum of patient care, from diagnosis and referral, selection of the appropriate cellular therapy product, collection and processing of the cells, preparative regimens, administration of the cellular therapy, post-administrative supportive care, and long-term follow-up and reporting.
Accredited cellular therapy programs have the robust infrastructure required to administer the right cellular therapy or cord blood unit to the right patient, at the right time, with the right management and supportive care available and implemented.
Our program offers comprehensive, compassionate and personalized care in a supportive environment for patients with blood disorders such as leukemia, lymphoma and multiple myeloma. We offer a highly specialized team approach to care for our patients, with a dedicated nurse coordinator who monitors each transplant patient and creates personalized treatment plans.
To schedule an appointment with one of our transplant specialists or for more information, call us at (702) 962-2100.
Cancer care in the community
In the past, many area patients who were diagnosed with blood cancers needed to relocate for complex care, separating themselves from their families, communities and jobs— essentially their entire support system—when it is needed the most.
With the Transplant and Cellular Therapy Program at MountainView Hospital, Nevada patients with blood cancers or disorders have access to vital transplant services—right in their own community.
What is a blood and marrow transplant?
A blood and marrow transplant, also called a bone marrow or stem cell transplant, is a procedure that takes unhealthy marrow cells and replaces them with healthy ones. The new marrow cells can then create healthy blood cells in the patient.
Our transplant services
At MountainView, we perform autologous transplants to fight blood cancers. These are blood and marrow transplants, often called stem cell transplants, where patients use their own stem cells to replace any diseased or damaged bone marrow to help fight cancer.
Most transplant patients require hospitalization at some point during the blood and marrow transplant process, although the length of the hospital stay will vary based on the type of transplant and the patient’s condition. MountainView's oncology unit was specially built to meet the unique needs of these patients.
Blood cancers we treat
Blood cancers and other disorders we treat include:
- Hodgkin lymphoma
- Leukemias, including high-risk acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML) and chronic leukemias
- Non-Hodgkin’s lymphoma
- Plasma cell diseases, including multiple myeloma and amyloidosis
- Testicular cancer
- Waldenstrom macroglobulinemia
Oncology alert patient care program
The Sarah Cannon Transplant and Cellular Therapy Program at MountainView Hospital offers an oncology alert patient care program, the only program in the region focusing on promptly identifying and treating immunocompromised oncology patients arriving through the cancer clinic or the emergency room (ER).
The program provides special training to ER and clinic teams to identify and address the unique needs of chemotherapy patients.
Our care team
Our bone marrow transplant team includes:
- Transplant physicians
- Advanced practice providers
- Cancer rehabilitation and occupational therapists
- Consulting specialists
- Social workers/case managers
- Transplant financial coordinator
- Transplant nurse coordinators/navigators
- Transplant nurses (inpatient/outpatient)
About the Sarah Cannon Transplant and Cellular Therapy Network
The Sarah Cannon Transplant and Cellular Therapy Program at MountainView Hospital is part of the Sarah Cannon Transplant and Cellular Therapy Network, which offers patients convenient, community-based access to complex blood cancer care including acute leukemia, blood and marrow transplantation, clinical trials and innovative therapies.
The network brings together patient-centered and physician-led blood cancer programs across the U.S. and U.K. and is one of the largest providers of blood and marrow transplants. In fact, it conducts about 1,200 transplants annually through eight FACT/JACIE* accredited transplant centers and has performed more than 15,000 transplants since its inception.
With a full menu of innovative care options, including access to the newest therapies, our care teams specialize in blood cancer care from diagnosis through survivorship.
Transplant and cellular therapy physicians see patients in the clinic daily, Monday through Friday, and are on call 24 hours, 7 days a week.